Terms: = Lymphoma AND MAF, MGC71685, 4094, ENSG00000178573 AND Diagnosis
7 results:
1. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract] [Full Text] [Related]
2. miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute lymphoblastic leukemia: A case-control study in Tunisia.
Dhiflaoui A; Mahjoub S; Chayeb V; Achour B; Chouchen S; Abdennebi HB; Mahjoub T; Almawi WY
Gene; 2022 Aug; 834():146648. PubMed ID: 35690283
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of c-maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Natkunam Y; Tedoldi S; Paterson JC; Zhao S; Rodriguez-Justo M; Beck AH; Siebert R; Mason DY; Marafioti T
Am J Clin Pathol; 2009 Sep; 132(3):361-71. PubMed ID: 19687312
[TBL] [Abstract] [Full Text] [Related]
4. In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report.
Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
Acta Biochim Pol; 2002; 49(1):221-5. PubMed ID: 12136944
[TBL] [Abstract] [Full Text] [Related]
5. Recent advances in the molecular pathogenesis of lymphomas.
Sarris A; Ford R
Curr Opin Oncol; 1999 Sep; 11(5):351-63. PubMed ID: 10505771
[TBL] [Abstract] [Full Text] [Related]
6. Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Kaspers GJ; Veerman AJ; Pieters R; Van Zantwijk I; Hählen K; Van Wering ER
Leuk Res; 1995 Mar; 19(3):175-81. PubMed ID: 7700079
[TBL] [Abstract] [Full Text] [Related]
7. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
[TBL] [Abstract] [Full Text] [Related]
